AMI Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
38,504
-1,259
-3% -$46.6K 0.08% 43
2025
Q4
$1.67M Buy
39,763
+4
+0% +$161 0.09% 41
2025
Q3
$1.36M Sell
39,759
-173
-0.4% -$4.96K 0.08% 48
2025
Q2
$1.08M Sell
39,932
-8,580
-18% -$249K 0.06% 46
2025
Q1
$1.44M Buy
48,512
+10,586
+28% +$403K 0.08% 51
2024
Q4
$1.5M Sell
37,926
-28,956
-43% -$1.1M 0.08% 52
2024
Q3
$2.28M Sell
66,882
-19,514
-23% -$549K 0.12% 40
2024
Q2
$1.87M Sell
86,396
-117,327
-58% -$2.47M 0.1% 41
2024
Q1
$4.51M Buy
203,723
+13,620
+7% +$332K 0.23% 40
2023
Q4
$5.23M Sell
190,103
-5,480
-3% -$132K 0.29% 39
2023
Q3
$4.37M Buy
195,583
+24,585
+14% +$632K 0.27% 43
2023
Q2
$4.36M Buy
170,998
+7,422
+5% +$180K 0.26% 45
2023
Q1
$3.65M Buy
+163,576
New +$3.95M 0.23% 51

Other funds holding VCYT

AMI Asset Management's VCYT Position: Q1 2026 in Review

AMI Asset Management reduced its Veracyte (VCYT) stake by 3.2% in Q1 2026, selling an estimated $46.6K and leaving 38,504 shares worth $1.24M. The position accounts for 0.08% of the portfolio, ranked #43.

AMI Asset Management first reported a position in VCYT in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.23M in Q4 2023. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • AMI Asset Management held 38,504 shares of Veracyte worth $1.24M as of Q1 2026.
  • AMI Asset Management sold 1,259 Veracyte shares in Q1 2026, an estimated $46.6K.
  • Veracyte made up 0.08% of AMI Asset Management's portfolio in Q1 2026, its #43 holding.
  • AMI Asset Management first reported a position in Veracyte in Q1 2023 and has held it in 13 quarters since.
  • AMI Asset Management's Veracyte position peaked at $5.23M in Q4 2023.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on AMI Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.